Latest News
The Art of Gene Therapy Digital Summit: EMEA 2021April 30, 2021 - 12:39 pm
The caking challenge: Are granulated materials a good way to overcome it?March 31, 2021 - 9:12 am
Congratulations EU Advance Biotech Grants Semifinalists!March 25, 2021 - 11:34 am
Register for ADC Webinar – March 25, 2021March 15, 2021 - 10:10 am
Register for Biotech Start-up SymposiumMarch 3, 2021 - 3:45 pm
How the Vaccine Industry and Biotechs Can Accelerate Pandemic ResponsesFebruary 19, 2021 - 6:46 am
Mind the Gaps: A Perspective from the World of Academic Spinouts
/in Uncategorized /by Michele WashkoDepending upon your perspective, “emerging” biotech could mean any number of things, ranging all the way from the recent spinout of an academic lab to a publicly held company developing a therapeutic that has not yet reached the marketplace. My company, Respana Therapeutics (a finalist in North America Advance Biotech Grant Program) sits at the […]
Investment in Internal Process Development and Manufacturing Enables Rapid Product Development
/in Bioprocessing, Frontpage Article /by Alex MeolaSpeed to the clinic and patient safety are important goals when working to bring novel genetic therapies to patients. To achieve these goals, Homology Medicines decided to invest in internal development and manufacturing operations not long after the Company’s founding, which included the construction of a 25,000 sq ft GMP manufacturing facility adjacent to its […]
The Art of Gene Therapy Digital Summit: EMEA 2021
/in Uncategorized /by Jessica Hoganinvites you to the Art of Gene Therapy digital summit, a free five-session event drawing on the collective experience of industry leading gene therapy companies and regulatory agencies. The digital summit will shine a light on gene therapy future technologies, technical challenges, lessons learned from scale up to commercialization and what is on the horizon […]
Congratulations, VectorY
/in Bioprocessing /by Jessica HoganCongratulations to the team at VectorY for being awarded the 2021 European Advance Biotech Grant grand prize of €255,000 in products, services and consultation. With a large number of applicants this year, 6 semi-finalist companies were selected to present directly to the panel of judges, from there- 3 finalist companies were selected to move forward. […]
A new shared-risk partnership model for developing and commercializing oncology innovations – April 23 2021
/in Webinar /by Ned WakemanClick HERE to register for a LIVE presentation from industry expert Ned Wakeman on A New Shared-risk Partnership Model for Developing and Commercializing Oncology Innovations. Abstract includes: Developing and commercialising new oncology medicines, biomarkers and models requires a multi-disciplinary, collaborative approach and has historically been conducted by large Pharma companies. The closure of Pharma sites in the […]
Diagnosing, targeting and treating cancer using a recombinant cancer binding malaria protein – April 23 2021
/in Webinar /by Ali Salanti M.Sc., PhDClick HERE To register for a LIVE presentation from industry expert Ali Salanti (PhD) on Diagnosing, targeting and treating cancer using a recombinant cancer binding malaria protein. Abstract includes: Rapid growth and tissue invasion are features shared by cancer and the placenta. For the placenta this is essential to support fetal growth but in cancer it is detrimental. Malaria parasites have evolved a protein called VAR2CSA that binds a distinct carbohydrate modification present on placental cells. This placental CSA is not found on normal somatic cells, and VAR2CSA is the only reagent that can distinguish normal CSA from placental CSA. We have shown that placental CSA […]